Burkholderia glumae causes both rice seedling rot in nursery boxes and grain rot in the field after the heading stage (10) . The bacterium produces a host-nonspecific phytotoxin, toxoflavin, which is a major virulence factor (23, 26) . The biosynthetic genes of toxoflavin are polycistronic and are composed of five genes, toxABCDE. The genes responsible for toxoflavin transport, toxFGHI, are polycistronic and similar to the genes for the resistance-nodulation-division efflux systems (15) . Using Tn3-gusA reporter fusions, we reported previously that expression of both the toxABCDE and toxFGHI operons is controlled by quorum sensing (QS), which depends on Noctanoyl homoserine lactone biosynthesized by TofI and its cognate receptor TofR (15) . The active form of TofR then activates the expression of the transcriptional activator ToxJ, which is required for expression of both tox operons (15) . In addition to QS and ToxJ, the LysR-type transcriptional regulator (LTTR) ToxR is required for the expression of both tox operons in the presence of toxoflavin as a coinducer (15) .
All LTTRs are DNA-binding proteins that regulate the transcription of target genes, and most of them also negatively regulate their own transcription (27, 28) . Most LTTRs form dimers or tetramers, have a helix-turn-helix (HTH) motif in their N-terminal domains, and require a small molecule as a coinducer (7, 27) . A consensus nucleotide sequence, T-N 11 -A, located in the regulatory region of LTTRs has been identified as a DNA binding site (27) . The central region is somewhat dissimilar among LTTRs. Mutational analyses of some LTTRs have suggested that two subdomains of the central region are involved in coinducer recognition and response (3, 13, 16, 17, 27) . Evidence obtained from AmpR (1), OxyR (16) , CysB (18) , and NahR (28) has indicated that the C-terminal domain regions are involved in the multimerization of LTTRs and demonstrates that these functions can be separated genetically.
Previously, with the support of genetic analysis, we identified the T-N 11 -A consensus sequence in the upstream region of the toxABCDE and toxFGHI operons and proposed that ToxR directly regulates the expression of both operons (15) . Likewise, we also suggested that expression of the two tox operons is regulated directly by ToxJ (15) . However, our conclusion was based only on genetic evidence, and direct and physical evidence to support our suggestion was not provided. It was also curious how two transcription factors work together in the same regulatory region of the two operons.
Here, we identified ToxR binding sites in the regulatory regions of the two operons, and we provide physical evidence for the simultaneous binding of ToxR and ToxJ to the regulatory regions. Based on mutational analysis of ToxR, we propose specific amino acid residues that are critical to ToxR activity. We also found that toxoflavin is a specific coinducer among toxoflavin derivatives, including reumycin and fervenulin, which are produced naturally by B. glumae.
MATERIALS AND METHODS
Strains, plasmids, and culture media. The strains and plasmids used in this study are listed in Table 1 . The Escherichia coli strains used for plasmid DNA transformation or conjugational transfer of plasmids were grown in Luria broth ([LB] 10 g liter Ϫ1 Difco Bacto-tryptone, 10 g liter Ϫ1 Difco yeast extract, and 5 g liter Ϫ1 NaCl, pH 7.2) with or without 1.5% (wt/vol) agar. Unless noted otherwise, the B. glumae strains were grown in LB medium. When required, appropriate antibiotics were added to the medium as follows: 50 g ml Ϫ1 ampicillin, 100 g ml Ϫ1 rifampin, 100 g ml Ϫ1 spectinomycin, and 10 g ml Ϫ1 tetracycline.
General DNA manipulations and conjugation. Isolation of plasmid and genomic DNA and transformation into E. coli DH5␣ were carried out according to Sambrook and Russell (25) . Restriction and DNA-modifying enzymes (New England Biolabs) were used as recommended by the manufacturer. DNA fragments were purified from agarose gels using a QIAEX II gel extraction kit (Qiagen). PCR amplification was performed using an MJ Research PTC-200 system (Bio-Rad) and standard protocols. All pLAFR3 and pLAFR6 derivatives were mobilized into B. glumae by conjugation, as described previously (15) .
Overexpression and purification of ToxR and ToxJ. To overexpress ToxR in E. coli, the coding region of toxR was amplified using the chromosomal DNA of B. glumae BGR1 as the template and the oligonucleotide primers TOXR1 and TOXR2 ( Table 2 ) that incorporate unique NdeI and BamHI sites at the ends of the PCR product to facilitate cloning into pET14b (Invitrogen) as a transcriptional fusion to the T7 promoter. DNA sequences of the amplified DNA were confirmed by sequencing using an ABI Prism BigDye terminator cycle sequencing kit (version 2.0; Perkin-Elmer) and the T7 promoter and T7 terminator primers. The resultant plasmid, pTOXR-His, encoded ToxR with a His 6 tag at the N terminus and was introduced into E. coli strain BL21 (Novagen) and cultured at 28°C in 1 liter of LB medium. The culture was incubated to mid-log phase (A 600 of 0.4), at which point isopropyl-␤-D-thiogalactopyranoside (0.5 mM final concentration) was added. The induced culture was incubated for another 4 h at 28°C. Cells were harvested and resuspended in lysis buffer (20 mM Tris-HCl [pH 7.6], 0.5 mM EDTA, 1 mM dithiothreitol [DTT], 15% glycerol). Cells were disrupted by sonication with a VCX-400 sonicator (Sonics and Materials), and the lysate was cleared by centrifugation (10,000 ϫ g for 20 min). His-tagged proteins were purified using Ni-nitrilotriacetic acid spin columns as described by the manufacturer (Qiagen). The eluted protein was dialyzed in storage buffer (lysis buffer supplemented with 50% glycerol) to remove the imidazole and then stored at Ϫ20°C. The concentration of the purified protein was determined by the Bradford method with bovine serum albumin as the standard (2) .
For overexpression of ToxJ, the coding region of toxJ was amplified using the chromosomal DNA of B. glumae BGR1 as the template and oligonucleotide primers TOXJ1 and TOXJ2 ( Table 2 ) that incorporate unique NdeI and BamHI sites at the ends of the PCR product, followed by ligation into the corresponding sites of pET14b. The resultant plasmid, pTOXJ-His, was transformed into E. coli BL21, and His-tagged ToxJ was purified as described above.
Gel filtration. We estimated the molecular weights of the purified His-ToxR and His-ToxJ using a Superdex 200-HR 10/30 column with an AKTA Explorer fast protein liquid chromatography system (Amersham Biosciences). The column was equilibrated with extraction buffer (20 mM Tris-HCl [pH 7.6], 100 mM NaCl, 1 mM DTT, 1 mM EDTA), and the molecular mass of the eluted protein was estimated by a calibration curve prepared using the elution times measured for protein standards (Bio-Rad and Amersham Biosciences), ranging from 1.35 to 670 kDa (thyroglobulin, 670 kDa; gamma globulin, 158 kDa; albumin, 67 kDa; ovalbumin, 44 kDa; myoglobin, 17 kDa; vitamin B 12 , 1.35 kDa). The proteins were each loaded onto the gel filtration column, and the elution was followed at 280 nm.
Gel mobility shift assay. The 400-bp upstream region of toxA was amplified by PCR using TAP1 and TAP2 primers ( Table 2 ). The 198-bp upstream region of toxF was also amplified using TFP1 and TFP2 primers ( Table 2 ). The DNA fragments were eluted from the agarose gel and labeled with biotin for chemiluminescence using a light-shift chemiluminescent electrophoretic mobility shift 
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assay kit (Pierce Biotechnology). Purified His-ToxR or His-ToxJ was incubated with target DNA (2 nM) in binding buffer [10 mM Tris-HCl (pH 7.6), 10 mM KCl, 0.5 mM EDTA, 1 mM DTT, 5% (vol/vol) glycerol, and 1 g l Ϫ1 poly(dIdC)] for 15 min at 28°C. Mixtures were size fractionated on a nondenaturing 4% polyacrylamide gel, followed by transfer to nitrocellulose membranes and detection by streptavidin-horseradish peroxidase and chemiluminescence for biotinlabeled probes. In competition analyses for ToxR and ToxJ, we used the 252-bp upstream region of toxJ amplified using primers TJP2 and TJP3 and the 242-bp upstream region of katE amplified using primers KEN1 and KEN2 (Table 2) . For simultaneous binding, 10 nM biotin-labeled DNA was incubated with His-ToxR (75 nM) and His-ToxJ (150 nM) in the same binding buffer.
DNase I footprinting. DNase I footprinting reactions of the toxA regulatory region were carried out by PCR amplification using 32 P-labeled TAP1 and unlabeled TAP2 primers (Table 2 ). For DNase I footprinting of the toxF promoter region, unlabeled TFP1 and 32 P-labeled TFP2 were used as primers ( Table 2 ). The primer was end labeled with [␥-32 P]ATP using T4 polynucleotide kinase (Epicentre). DNase I protection assays were performed as described by Sambrook and Russell (25) with slight modifications. The labeled DNA (300 ng) was suspended in 20 l of reaction solution containing 1ϫ binding buffer as described above for the gel mobility shift assays, 1 g of poly(dI-dC), and various concentrations of ToxR. The reaction mixtures were incubated at 25°C for 20 min. Then, 20 l of 10 mM MgCl 2 -5 mM CaCl 2 was added along with 1 l of a DNase I solution (10 ng l Ϫ1 ; Sigma). Samples were incubated for 1 min at 25°C, and the reactions were stopped by the addition of 80 l of stop solution (25) . The DNA products were purified using ethanol precipitation. To identify the DNase I protection region, sequencing reactions were performed using a SequiTherm cycle sequencing kit (Epicentre). Samples were extracted with 1 volume of phenol-chloroform, precipitated with ethanol, resuspended in formamide loading dye, and separated on 4% polyacrylamide gels containing 7 M urea and Tris-borate-EDTA buffer (25) .
Construction of the reporter strain S6K34 and ␤-glucuronidase assay. To study the functions of ToxR mutants and to test which toxoflavin derivatives are functional as coinducers of ToxR, we needed to construct a toxRЈAЈ::⍀ toxF::Tn3-gusA34 strain. The ⍀ cassette from pHP45⍀ (Table 1) was inserted into the unique MfeI-EcoRI site within the toxR and toxA region in pBGT37 to give pBGT61. This plasmid was introduced into B. glumae BGK34 (BGR1 toxF::Tn3-gusA34 strain) ( Table 1) to generate the BGR1 toxF::Tn3-gusA34 toxRЈAЈ::⍀ mutant strain (S6K34) by marker-exchange mutagenesis. Marker exchange was confirmed by Southern hybridization using pBGT17 as a DNA probe as described previously (15) . For the expression assays, 1 M toxoflavin or its derivatives was added to the cultures. The ␤-glucuronidase assay was performed as described previously (11) .
Random mutagenesis. Random mutagenesis of toxR was performed using error-prone PCR (30) and hydroxylamine mutagenesis (19) . For error-prone PCR, pBGT39 was used as a template with M13-20 and M13 reverse primers ( Table 2 ). The PCR products were digested with EcoRI and BamHI and cloned into the corresponding sites of pBluescript II SK(ϩ) (Promega). For hydroxylamine mutagenesis, 10 g of pBGT39 was incubated in a reaction mixture containing 0.5 M hydroxylamine and 5 mM EDTA in 0.1 M potassium phosphate (pH 6.0) for 4, 8, or 12 h at 50°C or for 12 or 24 h at 37°C. After the treatment, the reaction mixtures were dialyzed overnight in TE buffer (10 mM Tris-HCl [pH 7.0], 1 mM EDTA) to remove the hydroxylamine. The mutated DNA fragments containing toxR in pBluescript II SK(ϩ) were sequenced to confirm the presence of the mutations.
Immunodetection of ToxR mutants. Each toxR mutant was amplified using ToxR1-1 and ToxR3-1 primers (Table 2 ) and cloned into the NdeI and BamHI sites of pET14b as described above. Each ToxR mutant was purified by the same method used for the wild-type ToxR. Purified ToxR mutant proteins were separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (12% polyacrylamide) and then transferred to Hybond-P membrane (Amersham Pharmacia Biotechnology) by electroblotting at 25 V for 60 min in transfer buffer (48 mM Tris, 39 mM glycine, 0.037% [wt/vol] sodium dodecyl sulfate, 20% [vol/vol] methanol, pH 8.3). For immunoblot detection, a mouse polyclonal anti-ToxR antibody was raised against a synthetic peptide (LEPPEFDPSQAQR) and used as the primary antibody, and alkaline phosphatase-conjugated goat anti-mouse immunoglobulin G (Pierce Biotechnology) was used as the secondary antibody. Positive signals were detected using One-Step NBT/BCIP (nitroblue tetrazolium/ 5-bromo-4-chloro-3-indolylphosphate) solutions (Pierce Biotechnology).
Synthesis of toxoflavin, fervenulin, reumycin, and their analogs. Toxoflavin, fervenulin, reumycin, and their analogs, 3-methyltoxoflavin, 3-phenyltoxoflavin, 3-methylreumycin, 3-phenylreumycin, 3-methylfervenulin, 4,8-dihydrotoxoflavin, 5-deazaflavin, 3-methyl 4,8-dihydrotoxoflavin, and 6,9-dimethyl-8-oxo-6,9 dihydro-6-azapurine, used in this study were synthesized as described by Nagamatsu (23) . Stock solutions of 10 mM in methanol (high-performance liquid chromatography grade) were diluted into the growth medium to give the stated concentrations.
RESULTS
ToxR is a tetramer and ToxJ is a dimer. To characterize the oligomeric status of ToxR and ToxJ, freshly purified His-ToxR and His-ToxJ were separated by size exclusion chromatography. His-ToxR showed one major peak at 127 kDa, corresponding to a tetramer, and His-ToxJ exhibited one major peak at 60 kDa, corresponding to a dimer (Fig. 1B and C) . When toxoflavin was added to the purified His-ToxR, its tetrameric form did not change (data not shown). Both ToxR and ToxJ bind to the regulatory regions of the two tox operons. To determine whether ToxR and ToxJ bind directly to the regulatory regions of the two tox operons, gel mobility shift assays were performed with the biotin-labeled DNA fragments. His-ToxR at 75 nM resulted in a shift in the mobility of the DNA fragment containing the regulatory regions of the two tox operons (Fig. 2A) . With the DNA fragment of the toxA promoter region, two complexes, CI and CII, were observed ( Fig. 2A) . His-ToxJ at 150 nM conferred the mobility shift of the same DNA fragment used for the HisToxR binding assay (Fig. 2B) . To further investigate whether ToxR and ToxJ bind simultaneously to the regulatory region of the two tox operons, gel mobility shift assays were conducted with one or both proteins. When the same toxF promoter region DNA fragment used for the His-ToxJ binding assays was treated with 150 nM His-ToxJ, but at a higher DNA concentration, two DNA-ToxJ complexes were observed (Fig. 2C) .
When 75 nM His-ToxR and 150 nM His-ToxJ were applied together to the same DNA fragment used for His-ToxR and Hi-ToxJ binding assays, free labeled DNA was not observed, and larger DNA-protein complexes appeared (Fig. 2C) . This indicated that both ToxR and ToxJ bind simultaneously to the regulatory region of the two tox operons. To determine whether toxoflavin affects ToxR binding to the target DNA regions of toxA and toxF, we performed gel mobility shift assays of ToxR with or without toxoflavin. There was no difference in the gel mobility shift patterns with or without toxoflavin (data not shown).
Identification of binding sites for His-ToxR using DNase I protection analysis.
To determine the precise sites of ToxR binding in the regulatory region of the toxFGHI operon, a DNase I footprinting experiment was performed using a 198-bp DNA fragment. As shown in Fig. 3A , the DNase I protection revealed a clear protection pattern by ToxR in the upstream region of toxFGHI. Six bases within the protected region of the toxF regulatory region appeared to be hypersensitive to digestion by DNase I. The protected region overlapped with a consensus sequence for the ToxR binding DNA fragment (Fig. 3A) . The sequences for the binding of ToxR to the regulatory region of toxABCDE were also mapped by DNase I footprinting using a 400-bp fragment (Fig. 3B) . Three regions were identified in this fragment, supporting the previous prediction that ToxR may bind to more than three sites in the toxABCDE regulatory region. The sequences for the binding of ToxR to the regulatory regions of both tox operons possessed T-N 11 -A motifs (Fig. 3) .
ToxR autoregulates its own expression. Since ToxR binds to its own putative gene promoter, we determined how ToxR affects its own gene expression. We measured the ␤-glucuronidase activity of the BGR1 toxR::Tn3-gusA43 mutant with or without pBGT40 carrying a toxR gene. The ␤-glucuronidase activity of BGR1 toxR::Tn3-gusA43 mutant was 4.4 (10 Ϫ11 U/CFU) and 0.1 (10 Ϫ11 U/CFU) without and with pBGT40, respectively.
Characterization of ToxR mutants. To identify amino acid residues critical to ToxR functions, we constructed the reporter strain S6K34 (toxF::Tn3-gusA34 toxRЈAЈ::⍀) ( Table 1 and Fig. 4) . The expression level of ␤-glucuronidase was monitored when the plasmids carrying each ToxR mutant were transferred into S6K34 along with 1 M toxoflavin as a coinducer. Ten plasmids, each carrying a single amino acid residue substitution in ToxR, were analyzed. The wild-type ToxR activated the expression of ␤-glucuronidase in the S6K34 strain as expected (Fig. 5A ). In the presence of toxoflavin, the mutant A121V exhibited a level of toxF expression equivalent to that of wild-type ToxR (Fig. 5A and B) . Mutants T239A and E272K exhibited 25 to 40% activity compared to the wild-type ToxR (Fig. 5A and B) . The mutants H32Q, F154L, A172P, I225T, L250P, P265L, and H287R lost ToxR activity in the presence of toxoflavin ( Fig.   5A and B) . We did not observe any toxoflavin-independent mutants that activated toxF expression.
To confirm that the reduced activity of the ToxR mutants was not due to protein instability, ToxR mutants were detected using immunoblotting. As shown in Fig. 5C , each ToxR derivative was expressed successfully and cross-reacted with polyclonal anti-ToxR antibodies. This indicated that the loss of activity of the mutants was not due to instability of the proteins.
Toxoflavin is a specific coinducer of ToxR. To determine whether toxoflavin is a specific coinducer for ToxR, we tested toxoflavin, fervenulin, reumycin, and their derivatives by evaluating the expression levels of toxA in the strain BGK59 (toxA::Tn3-gusA59). Toxoflavin at 10 M strongly activated toxA expression, and 4,8-dihydrotoxoflavin did so slightly, whereas the others failed to activate expression of toxA (Fig.  6 ). This result indicates that toxoflavin is a specific coinducer of ToxR. 
DISCUSSION
In a previous study, we reported genetic evidence that the two tox operons containing genes for toxoflavin biosynthesis and transport are polycistronic and regulated by the two transcriptional regulators ToxJ and ToxR (15) . We previously proposed the highly conserved sequence motif T-N 11 -A as a putative binding site for ToxR and inverted repeat sequences as putative ToxJ binding sites in the regulatory region of the two operons (15) . In the present study, we have provided biochemical and physical evidence that ToxJ and ToxR bind simultaneously to the two tox operons. When 10 nM toxF promoter region DNA was used for ToxJ binding, two DNA-ToxJ complexes appeared (Fig. 2C) . The size of the complexes increased gradually with the ToxJ concentration (data not shown). This indicates that ToxJ polymerizes along the toxF promoter region DNA. Similar multiband patterns have been observed in DNA binding of SarZ in Staphylococcus aureus (14) .
LTTRs, such as NahR, CysB, and OxyR, form tetramers, whereas MetR, NodD3, and Nac appear to form dimers (5, 20, 22, 28) . Previous genetic evidence that expression of tox genes requires both ToxR and ToxJ has raised the question of how ToxR binds to the regulatory regions of the two tox operons at multiple sites together with ToxJ. In DNase I protection assays, the protected DNA sequences of the toxF regulatory region by His-ToxR binding overlapped with the putative promoter region of the toxR gene. It is thought that ToxR-mediated gene regulation in B. glumae is somewhat similar to that in LTTRs, in a sense that most LTTRs repress their own transcription, probably to maintain constant protein levels (27) . Specific DNA sequences for ToxR binding were consistent with the previously reported results that most LTTRs bind to the conserved T-N 11 -A motif (6) . These ToxR binding sites overlapped each other in both tox operons, consistent with the fact that they are often found in the binding sites for LTTRs. Given that coinducers introduce DNA bending after binding to the LTTRs, some DNA sequences of ToxR were hypersensitive to DNase I digestion, especially in the toxFGHI operon, which is suggestive of a possible DNA bending region.
The present study indicates that both ToxR and ToxJ bind to the same region of the two tox operons. However, it is not clear whether the simultaneous binding of ToxR and ToxJ to the same region is cooperative or synergistic. What it is clear is that the bacterial cells ensure that toxoflavin production is controlled tightly by keeping toxJ expression under the control of QS. This, together with the fact that ToxR uses toxoflavin as a coinducer, suggests that bacterial cells produce toxoflavin unless they reach a certain cell density. To our knowledge, this is the first report that a transcriptional regulator belonging to the LTTRs works together with another transcriptional activator to express target genes.
The C-terminal domain of tetrameric LTTRs is critical for DNA binding while the C terminus of the dimeric LTTRs seems to be dispensable for DNA binding (27) . This difference suggests that there may be at least two subclasses of LTTRs: one subgroup is able to bind and activate as dimers, and the other functions as tetramers (27) . Therefore, based on the size exclusion data and mutational analysis of ToxR, it appears that ToxR belongs to the second subgroup, functioning as a tetramer.
We analyzed the properties of 10 ToxR mutants to define the roles of particular amino acid residues for the proposed functional map of ToxR. The fact that the H32Q mutant impaired the ability of ToxR to activate toxF expression suggests that the predicted HTH motif at residues 22 to 43 of ToxR and its close vicinity may be important for DNA binding, as predicted. This is consistent with the idea that the N terminus of the LTTR is highly conserved to function as a DNA binding motif. Two mutants, F154L and A172P, that lost activity might have defects in coinducer recognition and response since residues 95 to 173 of ToxR are conserved among LTTRs and function as a coinducer recognition and response region (27) . The LTTR C terminus is important for DNA binding and multimerization (27) . Six mutations in this region exhibited a loss of ToxR activity or reduced activity of ToxR, which is consistent with the predicted functions of LTTRs.
In other LTTRs, coinducer-independent mutants have been isolated. For example, substitutions at positions 231 or 252 in NahR (28) or at 234 in OxyR cause a coinducer-independent phenotype (16, 17) . Some substitutions of NodD, CysB, and NahR also produce a coinducer-independent phenotype (4, 8, 21) . Such mutations may alter the conformation of LTTRs in a way that mimics the change caused by binding of the coinducer. However, in the course of screening mutants of ToxR, we did not find a mutant that elicits a toxoflavin-independent phenotype. This may have been due to the number of ToxR mutants screened, or it may be that toxoflavin binding to ToxR is absolutely necessary for ToxR functions.
Among toxoflavin and its derivatives, toxoflavin and 4,8-dihydrotoxoflavin strongly and slightly induced ␤-glucuronidase activity in the reporter strain BGK59, respectively. This is probably due to the conversion of 4,8-dihydrotoxoflavin into toxoflavin, which occurs by oxidation (23) . Therefore, it is conclusive that toxoflavin is a highly specific coinducer of ToxR. We do not know how toxoflavin influences ToxR activity, but it is believed that coinducer binding to ToxR may signify DNA bending or protein-DNA interactions that increase the affinity for RNA polymerase, causing increased initiation of transcription.
